en
Professional article
French

Thromboprophylaxie hospitalière : doit-on adapter la dose d'énoxaparine au poids des patients ?

Published inRevue médicale suisse, vol. 13, no. 579, p. 1788-1791
Publication date2017
Abstract

Venous thromboembolism (VTE) is a common condition affecting hospitalized patients and it is associated with increased mortality, length of stay and health-care costs. Prophylaxis using low-molecular weight heparins (LMWH) is an efficient intervention preventing VTE in high-risk patients, yet some evidence suggests suboptimal prophylaxis in obese inpatients. This narrative review evaluates current evidence, both on clinical and surrogate outcomes, which can guide the adaptation of prophylactic doses of enoxaparin among obese medical inpatients.

Citation (ISO format)
TOGNON, Mikael et al. Thromboprophylaxie hospitalière : doit-on adapter la dose d’énoxaparine au poids des patients ? In: Revue médicale suisse, 2017, vol. 13, n° 579, p. 1788–1791.
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1660-9379
350views
1downloads

Technical informations

Creation11/13/2018 10:47:00 AM
First validation11/13/2018 10:47:00 AM
Update time03/15/2023 3:16:16 PM
Status update03/15/2023 3:16:16 PM
Last indexation01/17/2024 4:32:08 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack